Euretina Innovation Spotlight (EIS)
Wednesday 30 September 2026 VIECON - Vienna Congress & Convention Center, Vienna
EIS Organising Committee
Prof. Anat Loewenstein
President
EURETINA
Dr. Kourous Rezaei
Co-opted Board Member
EURETINA
PROF. Martin Zinkernagel
General Secretary
EURETINA
Prof. Nicole Eter
PRESIDENT ELECT
EURETINA
Mr. Alistair Laidlaw
Past President
EURETINA
DARA CONLON
EXECUTIVE VICE-PRESIDENT
EURETINA
Contributors
Euretina is delighted to announce the following speakers and panellists confirmed to participate in the Euretina Innovation Spotlight (EIS) 2026:
Reza Abedian
Head of Business Development & Customer Solutions
SENSILE MEDICAL AG/GERRESHEIMER
David Almeida
Founder
CASExAI PRECISION MEDICINE LLC
Francesco Bandello
Past President
EURETINA
Dominik Beck
Head of Business Sector Surgery Posterior Segment
ZEISS MEDICAL TECHNOLOGY
James Blaha
CEO and founder
VIVID VISION
Paul Bresge
CEO
RAY THERAPEUTICS
Patrick Bussfeld
Head of Medical Affairs Pipeline Eye Health
BOEHRINGER INGELHEIM
Daniel Chao
Vice President and Head of Clinical Development
SURROZEN
Rodolphe Clerval
CEO
COAVE THERAPEUTICS
Laura Distefano-Dominguez
RETINAROUTE MEDICAL
Brad Doerschuk
President and CEO
INFOCUS CLINICAL RESEARCH
Kenji Fujita
CMO
ATSENA THERAPEUTICS
Ulrich Granzer
CEO
GRANZER REGULATORY CONSULTING & SERVICES
Andrea Giani
Chief Medical Officer
MGSHELL SRL
Anta Gkelou
PhD
SOFINNOVA PARTNERS
Mahmut Gökkan
Founder
AI4VISION HEALTH TECHNOLOGIES INC
Abhi Gupta
Executive Vice President, Commercial & Business Development
OCUGEN INC
Erin C. Henry
PhD, AVP Ophthalmology, Global Medical & Scientific Affairs
MSD EYE BIO
Nancy M. Holekamp
MD, Principal Global Medical Science Leader PDMA Ophthalmology
ROCHE
Frank Holz
Past President
EURETINA
Horia Ijacu
Head of International Eyecare & Specialty
ABBVIE
Daniel Jones
PhD, Head of Global Medical Affairs, SYFOVRE and EMPAVELI
BIOGEN
Peter K. Kaiser
MD, Chief Development Officer
OCULAR THERAPEUTIX
Semin Kim
Assistant Manager Global Business
SANGMYUNG INNOVATION
Arshad Khanani
MD, MA
David Kirn
MD, Chief Executive Officer
4D MOLECULAR THERAPEUTICS
Caroline Klaver
Board Member
EURETINA
Laura Kovanda
PhD, VP, Team Lead, Asset Lead, BioPharma and Ophthalmology Development
ASTELLAS PHARMA INC.
Ash Kras
CEO and Co-founder
SANRO HEALTH
Alistair Laidlaw
co-founder
COMPLOG CLINICAL VISION MEASUREMENT SYSTEMS LTD
Paolo Lanzetta
Board Member
EURETINA
Sergio Leal
MD, Vice President Ophthalmology Development Lead
BAYER
Bart Leroy
Board Member
EURETINA
Luis Lesmes
CEO
ADAPTIVE SENSORY TECHNOLOGY
Amber Lewis
Director II, Clinical Development
ABBVIE
Stéphanie Magazzeni
Chief Scientific Officer
HEIDELBERG ENGINEERING
Carl-Joe Mehanna
Co-founder
ARTBRAINS SAS
Andreas Mitsios
Founder EyeLinked
ALCMAEON VISION SINGLE MEMBER P.C.
Tomas Navratil
PhD, Chief Development Officer
GLAUKOS CORPORATION
Elisa Petris
PhD
SYNCONA
Nikolas Pontikos
EYE2GENE
Carlos Quezada-Ruiz
MD, FASRS, Chief Medical Officer
ALKEUS
Kamilla Rolsted
CEO and Co-founder
EYGO BIO
Hendrik P.N. Scholl
CMO
BELITE BIO
Star Seyedkazemi
PharmD, Vice President of Development, Lilly Genetics Medicines Chief Development Officer, and Site Head
ADVERUM BIOTECHNOLOGIES, INC.
Riad Sherif
MD, CEO
OCULIS
Matthew Simunovic
RETINAL REPAIR INTERNATIONAL PTY LTD
Rich Small
CEO
NEUROTECH
Alfred Stett
CEO
OKUVISION GMBH
Jan Tode
Provider
OD-OS MACUTHERM
Patricia Udaondo Mirete
Board Member
EURETINA
Matt Van de Ven
CEO
MACUMIRA MEDICAL DEVICES INC.
John VeLure
CEO
I-LUMEN SCIENTIFIC, INC.
Ben Yerxa
PhD, President and Co-Founder
OPUS GENETICS
Philipp Zeitschel
CEO
SUPER CODE DOCTORS GMBH
Roger Zhang
PhD
AULIS CAPITAL